Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake: a Double-blind, Randomized, Placebo-controlled, Cross-over Study

NCT06556277 is registered in ClinicalTrials.gov with Eleonora Seelig as lead sponsor.

NCT NCT06556277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06556277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake: a Double-blind, Randomized, Placebo-controlled, Cross-over Study
Lead sponsor
Eleonora Seelig
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2024
Completion date
February 25, 2026
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucocorticoids, overeating, overweight and obesity